Who
Joshua Ruch
Director
Company insider
Files Form 4 as: Director, GeneDx Holdings; 10% owner, Rocket Pharmaceuticals; Director, Verenium; Director, Genvec; 10% owner, Nitromed.
In numbers
- Trades disclosed
- 102
- Buys
- 1
- Sells
- 1
- Bought
- $5.7M
- Sold
- $6.1M
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 22 Jun 2006
- Last trade
- 18 Jun 2026
- Last filed
- 23 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Jun 2026filed 23 Jun 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Code M | —3,576 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —4,248 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —3,576 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —4,248 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —3,576 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Code M | —3,576 at $0.00 | filing |
| 24 Nov 2025filed 26 Nov 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $32K201 at $158.40 | filing |
| 24 Nov 2025filed 26 Nov 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $100K625 at $159.28 | filing |
| 24 Nov 2025filed 26 Nov 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $143K889 at $160.45 | filing |
| 24 Nov 2025filed 26 Nov 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $180K1,117 at $161.16 | filing |
| 24 Nov 2025filed 26 Nov 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $12K72 at $162.04 | filing |
| 24 Nov 2025filed 26 Nov 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $64K407 at $158.40 | filing |
| 24 Nov 2025filed 26 Nov 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $202K1,268 at $159.28 | filing |
| 24 Nov 2025filed 26 Nov 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $290K1,805 at $160.45 | filing |
| 24 Nov 2025filed 26 Nov 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $366K2,268 at $161.16 | filing |
| 24 Nov 2025filed 26 Nov 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $24K147 at $162.04 | filing |
| 24 Nov 2025filed 26 Nov 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $319K2,016 at $158.40 | filing |
| 24 Nov 2025filed 26 Nov 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $1.0M6,279 at $159.28 | filing |
| 24 Nov 2025filed 26 Nov 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $1.4M8,944 at $160.45 | filing |
| 24 Nov 2025filed 26 Nov 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $1.8M11,234 at $161.16 | filing |
News
No headline names them, or the companies they trade most, lately.